Specific detection of tuberculosis infection: An interferon-γ-based assay using new antigens

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 1, 2004, Pages 59-64

  Mori, Toru ^a   Sakatani, Mitsunori ^b   Yamagishi, Fumio ^b   Takashima, Tetsuya ^b   Kawabe, Yoshiko ^b   Nagao, Keiji ^b   Shigeto, Eriko ^b   Harada, Nobuyuki ^b   Mitarai, Satoshi ^b   Okada, Masaji ^b   Suzuki, Katsuhiro ^b   Inoue, Yoshikazu ^b   Tsuyuguchi, Kazunari ^b   Sasaki, Yuka ^b   Mazurek, Gerald H ^b   Tsuyuguchi, Izuo ^b  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b NONE

Author keywords

Bacillus Calmette Gu rin; Diagnostics; IFN ; Infection; Tuberculosis

Indexed keywords

BCG VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; PROTEIN; PROTEIN CFP 10; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; EPITOPE; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HIGH RISK POPULATION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; METHODOLOGY; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; MALE; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

EID: 3242879865     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing [WHO report]. Geneva, Switzerland: World Health Organization; 2002.
2. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep 2000;49:1-51.
3. Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS. Comparison of a whole-blood Interferon γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286:1740-1747.
4. Brock I, Munk ME, Kok-Jensen A, Andersen P. Performance of whole blood IFN-γ test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001;5:462-467.
5. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1099-1104.
6. van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000;7:155-160.
7. Arend SM, Andersen P, Van Meijgaarden KE, Skjot RL, Subronto YW, van Dissel JT, Ottenhoff TH. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis 2000;181:1850-1854.
8. Munk ME, Arend SM, Brock I, Ottenhoff TH, Andersen P. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J Infect Dis 2001;183:175-176.
9. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ, Reece WH, Latif M, Pasvol G, Hill AV. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001;357:2017-2021.
10. Arend SM, Engelhard AC, Groot G, De Boer K, Andersen P, Ottenhoff TH, van Dissel JT. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin Diagn Lab Immunol 2001;8:1089-1096.
11. Noshiro T, Satoh K, Sato H, Miura Y. [Tuberculin survey of university students and postgraduates in 1998]. Kekkaku 2000;75:363-368.
12. Mori T. Recent trends in tuberculosis, Japan. Emerg Infect Dis 2000;6:566-568.
13. Bellete B, Coberly J, Barnes GL, Ko C, Chaisson RE, Comstock GW, Bishai WR. Evaluation of a whole-blood interferon-γ release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clin Infect Dis 2002;34:1449-1456.
14. Villarino ME, Burman W, Wang YC, Lundergan L, Catanzaro A, Bock N, Jones C, Nolan C. Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. JAMA 1999;281:169-171.
15. Duchin JS, Jereb JA, Nolan CM, Smith P, Onorato IM. Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. Clin Infect Dis 1997;25:661-663.
16. Villarino ME, Brennan MJ, Nolan CM, Catanzaro A, Lundergan LL, Bock NN, Jones CL, Wang YC, Burman WJ. Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standards. Am J Respir Crit Care Med 2000;161:1167-1171.
17. Rooney JJ Jr, Crocco JA, Kramer S, Lyons HA. Further observations on tuberculin reactions in active tuberculosis. Am J Med 1976;60:517-522.
18. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, et al. Depressed T-cell interferon-γ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999;180:2069-2073.
19. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, Hill AV, Lalvani A. Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217-5225.
20. von Reyn CF, Horsburgh CR, Olivier KN, Barnes PF, Waddell R, Warren C, Tvaroha S, Jaeger AS, Lein AD, Alexander LN, et al. Skin test reactions to Mycobacterium tuberculosis-purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001;5:1122-1128.
21. Swaminathan S, Gong J, Zhang M, Samten B, Hanna LE, Narayanan PR, Barries PF. Cytokine production in children with tuberculous infection and disease. Clin Infect Dis 1999;28:1290-1293.
22. + T cells to γ Interferon production in human tuberculosis. Infect Immun 2001;69:3497-3501.
23. Vekemans J, Lienhardt C, Sillah JS, Wheeler JG, Lahai GP, Doherty MT, Corrah T, Andersen P, McAdam KP, Marchant A. Tuberculosis contacts but not patients have higher γ interferon responses to ESAT-6 than do community controls in the Gambia. Infect Immun 2001;69:6554-6557.
24. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, Eguale T, Ravn P, Andersen P. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002;40:704-706.
25. Arend SM, Van Meijgaarden KE, De Boer K, De Palou EC, van Soolingen D, Ottenhoff TH, van Dissel JT. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002;186:1797-1807.
26. Vordermeier HM, Whelan A, Cockle PJ, Farrant L, Palmer N, Hewinson RG. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol 2001;8:571-578.
27. Food and Drug Administration, Center for Devices and Radiological Health. QuantiFERON-TB-P010033 [letter]. URL: www.fda.gov/cdrh/pdf/P010033b.pdf (Accessed February 7, 2004.)